这种成分是什么?

이 원료는 다음의 구조를 갖는 탄화수소이다.

成分列表

成分词典

HEXENE

1-hexene is an alkene that is hexane carrying a double bond at position 1.

定义

1-hexene is an alkene that is hexane carrying a double bond at position 1.

来源: PubChem

美国FDA 物质登记 · UNII B38ZZ8C206 · 登记名称 1-HEXENE · 单一化学物质

来源: 美国FDA 物质识别码（UNII）

化妆品中的作用

溶解其他成分的基质SOLVENT

安全与法规参考

未列入韩国有毒物质 GHS 分类 · 现有化学物质

来源: 韩国有毒物质 GHS 信息（环境公团）

Other restriction: ban substances that deplete the ozone layer

来源: 欧盟 CosIng 成分清单

详细资料——标示名称、识别编号、物性、试验记录、文献

别名和识别信息

HEXENEINCI헥센韩国标示名称（食药处标准名）1-Hexene同义名

CAS No.化学物质登记号: 592-41-6
EC No.欧盟化学品目录编号: 209-753-1
DTXSID美国EPA化学品编号: DTXSID4025402
DTXCID美国EPA化合物编号: DTXCID105402

IUPAC: Hex-1-ene
分子式: C6H12
分子量: 84.162 g/mol

实测物性

性状: 1-hexene appears as a clear colorless liquid with a petroleum like odor. Flash point -9 °F. Less dense than water and insoluble in water. Vapors heavier than air. Used as a solvent, paint thinner, and chemical reaction medium. · CBI, Liquid
沸点: 146.3 °F at 760 mmHg (USCG, 1999) · 63.4 °C @ 760 mm Hg
熔点: -219.6 °F (USCG, 1999) · -139.7 °C
溶解性: Very sol in ethanol, ethyl ether, benzene, and petroleum ether · In water, 50 mg/l at 25 °C
密度: 0.673 at 68 °F (USCG, 1999) - Less dense than water, will float · 0.6731 @ 20 °C/4 °C
黏度: 0.39 sq mm/s
熔点/凝固点: -140 ℃
初沸点和沸程: 63 ℃
闪点: -26 ℃(c.c.)
燃烧或爆炸范围上限/下限: 6.9 / 1.2 %
蒸气压: 18.7 ㎪ (20℃)
溶解度: 0.005 ( 20℃)
蒸气密度: 2.9
比重: 0.7
正辛醇/水分配系数（Kow）: 3.39
自燃温度: 253 ℃
分子量: 84.2

这是对物质本身测得的数值。韩国安全保健公团（KOSHA）的资料仅供编写和审核安全数据表参考，并非原料商品的规格。

来源: PubChem · 韩国安全保健公团安全数据表

产品实际使用的用途

这是向美国 EPA 申报含该成分的 17 款产品的用途。其中包括化妆品以外的产品，排在前几行的即为该成分的主要用途。

Monomers4
Intermediate3
Fuel2
Processing aids not otherwise specified2
Lubricating agent2
Viscosity modifier2
Solvent1
Surfactant (surface active agent)1

来源: 美国EPA CompTox

刺激与致敏试验记录

记录有皮肤试验 18 项、眼部试验 7 项。

归类为刺激性高3 项归类为中等3 项归类为低33 项

各项试验结论不一（最多的结论占 8%），因此不能断定该成分有刺激性。这是对原料本身的试验记录，与成品中所含浓度下的刺激性不同。

查看全部 25 项试验

Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to EU Method B.4 (Acute Toxicity: Dermal Irritation / Corrosion) according to EPA OTS 798.4470 (Acute Dermal Irritation) according to
Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to
Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) equivalent or similar to
Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to EU Method B.4 (Acute Toxicity: Dermal Irritation / Corrosion) according to
Not likely to be sensitizing
skin sensitisation: in vivo (non-LLNA) · Screening · equivalent or similar to OECD Guideline 406 (Skin Sensitisation)
Not likely to be sensitizing
skin sensitisation: in vivo (non-LLNA) · Screening · according to OECD Guideline 406 (Skin Sensitisation)
Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · other guideline: Federal Hazardous Substances Labelling Act (FHSLA) according to
Not classified
Skin Irritation · Screening
Not classified
Skin Sensitization · Screening
Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · other guideline: Federal Hazardous Substances Labeling Act (FHSLA) according to
Severe Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to
Moderate or Mild Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to
Category 6.3B (Category 3)
Skin Irritation · Read Across
Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · other guideline: U.S. EPA FIFRA (Pesticide Assessment Guidelines Subdivision F/TSCA (798.4470) according to OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to
Not likely to be sensitizing
skin sensitisation: in vivo (non-LLNA) · Screening · according to other guideline: Magnusson and Kligman
Severe Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) according to EU Method B.4 (Acute Toxicity: Dermal Irritation / Corrosion) according to EPA OTS 798.4470 (Acute Dermal Irritation) according to
Moderate or Mild Irritation
skin irritation: in vivo · Screening · OECD Guideline 404 (Acute Dermal Irritation / Corrosion) equivalent or similar to
Studies Indicate No Significant Irritation
skin irritation: in vivo · Screening · other guideline: Federal Hazardous Substance Labelling Act (FHSLA) according to
Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) equivalent or similar to
Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · other guideline: Federal Hazardous Substances Labeling Act (FHSLA) according to
Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · other guideline: Federal Hazardous Substances Labelling Act according to
Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) according to
Not classified
Eye Irritation · Screening
Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · other guideline: Federal Register 28 (110), 6.6.1963. paragraph 191.12 Test for eye irritants. according to
Studies Indicate No Significant Irritation
eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) according to EU Method B.5 (Acute Toxicity: Eye Irritation / Corrosion) according to